Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA center director change

This article was originally published in The Tan Sheet

Executive Summary

Center for Devices & Radiological Health Director Bruce Burlington, MD, will leave in mid-March to join Wyeth-Ayerst Labs as senior VP regulatory affairs. Burlington has headed CDRH since 1993. From 1988-1993, he was Office of Drug Evaluation II deputy director in the Center for Drug Evaluation & Research. Burlington, an 18-year FDA veteran, is the latest in a series of departures of experienced personnel from the agency. His departure suggests center directorships may not be as stable under FDA Commissioner Jane Henney, MD, as was expected. During the confirmation process, Henney noted she had recruited five of the six current center directors, including Burlington, during her previous tenure as deputy commissioner for operations. He served as acting director of the Office of Generic Drugs in 1989-1990 and started at FDA in the Center for Biologics Evaluation & Research in 1981
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS089324

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel